We are live on ! Find out more
AMYT

Amryt Pharma plc American Depositary Shares
AMYT

Delisted

AMYT was delisted on the 11th of April, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Amryt Pharma plc American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 79 → 0 (-79)

100% less funds holding in top 10

Funds holding in top 10: 11 → 0 (-11)

100% less capital invested

Capital invested by funds: $720M → $0 (-$720M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 79

Holders
–
Holders Change
-79
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
79
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
ACM
Athyrium Capital Management
New York
-$129M
2
HCM
Highbridge Capital Management
New York
-$92.3M
3
SCM
Stonepine Capital Management
Oregon
-$91.5M
4
MAM
MPM Asset Management
Massachusetts
-$38.9M
5
Morgan Stanley
Morgan Stanley
New York
-$36.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
Athyrium Capital Management
New York
– -$129M -8,857,268 Closed
HCM
2
Highbridge Capital Management
New York
– -$92.3M -6,333,552 Closed
SCM
3
Stonepine Capital Management
Oregon
– -$91.5M -6,278,085 Closed
MAM
4
MPM Asset Management
Massachusetts
– -$38.9M -2,668,843 Closed
Morgan Stanley
5
Morgan Stanley
New York
– -$36.5M -2,504,939 Closed
PCM
6
Pentwater Capital Management
Florida
– -$36.5M -2,500,000 Closed
UOC
7
UBS O'Connor
Illinois
– -$29.2M -2,000,000 Closed
TAL
8
TIG Advisors LLC
New York
– -$24.3M -1,666,821 Closed
AAM
9
Alpine Associates Management
Florida
– -$23M -1,577,900 Closed
RSCM
10
Rock Springs Capital Management
Maryland
– -$19.3M -1,325,625 Closed
GCL
11
Glazer Capital LLC
New York
– -$12.1M -830,168 Closed
NCM
12
Nantahala Capital Management
Connecticut
– -$12M -820,825 Closed
CC
13
Centiva Capital
New York
– -$11.5M -789,732 Closed
CC
14
Clearline Capital
New York
– -$9.19M -630,174 Closed
Barclays
15
Barclays
United Kingdom
– -$8.89M -609,546 Closed
WIC
16
Water Island Capital
New York
– -$8.52M -584,566 Closed
Hudson Bay Capital Management
17
Hudson Bay Capital Management
Connecticut
– -$8.32M -570,805 Closed
BMCM
18
Black Maple Capital Management
Wisconsin
– -$7.96M -545,693 Closed
Handelsbanken Fonder
19
Handelsbanken Fonder
Sweden
– -$7.66M -525,178 Closed
Bank of Montreal
20
Bank of Montreal
Ontario, Canada
– -$7.21M -494,578 Closed
Tudor Investment Corp
21
Tudor Investment Corp
Connecticut
– -$7.13M -488,700 Closed
WA
22
Whitebox Advisors
Minnesota
– -$6.8M -466,712 Closed
NLVP
23
New Leaf Venture Partners
New York
– -$6.56M -449,737 Closed
LP
24
LMR Partners
United Kingdom
– -$5.83M -400,000 Closed
Millennium Management
25
Millennium Management
New York
– -$5.55M -380,359 Closed
1
2 3 4

AMYT Hedge Fund Activity: Q2 2023 in Review

0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q2 2023, worth a combined $0 — down 100% from $720M a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of AMYT and 0 opened new positions — a net loss of 79 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Athyrium Capital Management, exiting entirely with an estimated $129M sold.

  • 0 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q2 2023, down from 79 in Q1 2023.
  • Funds reported $0 of Amryt Pharma plc American Depositary Shares stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Amryt Pharma plc American Depositary Shares positions in Q2 2023 and 79 closed out, a net change of -79 holders.
  • The largest Amryt Pharma plc American Depositary Shares seller in Q2 2023 was Athyrium Capital Management, an estimated $129M sold.

Based on aggregated 13F filings for Q2 2023.